Linnea Cipriano is a partner in Goodwin's Intellectual Property Litigation group. Her practice focuses on patent litigation in federal courts and the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB).
Ms. Cipriano has prosecuted and litigated patents in areas including pharmaceuticals, biologics, nutritional supplements, DNA-based technology, drug delivery technology, medical devices, cameras, and software. Ms. Cipriano has particular expertise in pharmaceutical litigation, including district court litigation under the Hatch-Waxman Act and BPCIA, and inter partes review (IPR) and post grant review (PGR) proceedings before the PTAB. Ms. Cipriano’s practice combines her in-depth knowledge of patent law with her scientific experience to serve her clients. She holds a graduate degree in pharmacology, and before pursuing a career in law, performed research at the Cleveland Clinic.